BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8762914)

  • 1. [Torsades de pointes in a patient under long-term maprotiline therapy. Apropos of a case].
    Rialan A; Richard M; Deutsch P; Ouattara B
    Ann Cardiol Angeiol (Paris); 1996 Mar; 45(3):123-5. PubMed ID: 8762914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tricyclic antidepressants, QT interval prolongation, and torsade de pointes.
    Vieweg WV; Wood MA
    Psychosomatics; 2004; 45(5):371-7. PubMed ID: 15345781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QT prolongation and Torsades de Pointes in patients previously treated with anthracyclines.
    Arbel Y; Swartzon M; Justo D
    Anticancer Drugs; 2007 Apr; 18(4):493-8. PubMed ID: 17351403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Torsade de pointes with amiodarone in a patient with previous torsade during beta-receptor blockade.
    Skanes AC; Morton BC; Green MS; Tang AS
    Can J Cardiol; 1997 Apr; 13(4):383-6. PubMed ID: 9141970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline values and sotalol-induced changes of ventricular repolarization duration, heterogeneity, and instability in patients with a history of drug-induced torsades de pointes.
    Couderc JP; Kaab S; Hinterseer M; McNitt S; Xia X; Fossa A; Beckmann BM; Polonsky S; Zareba W
    J Clin Pharmacol; 2009 Jan; 49(1):6-16. PubMed ID: 18957528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Concerning "Hemiparesis and torsades de pointes with low dosage sotalol therapy" by C. Sieber, Ph. Weiss and F. Follath (Schweiz. med. Wschr. 1990; 120: 1397-1399)].
    Liechti M
    Schweiz Med Wochenschr; 1991 Feb; 121(5):160. PubMed ID: 2003213
    [No Abstract]   [Full Text] [Related]  

  • 7. [Torsades de pointe with spiramycine and metiquazine therapy. Apropos of a case].
    Verdun F; Mansourati J; Jobic Y; Bouquin V; Munier S; Guillo P; Pagès Y; Boschat J; Blanc JJ
    Arch Mal Coeur Vaiss; 1997 Jan; 90(1):103-6. PubMed ID: 9137721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long QT syndrome and torsades de pointes induced by acute sulpiride poisoning.
    Chang JH; Weng TI; Fang CC
    Am J Emerg Med; 2009 Oct; 27(8):1016.e1-3. PubMed ID: 19857426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged QT interval and torsades de pointes associated with atazanavir therapy.
    Ly T; Ruiz ME
    Clin Infect Dis; 2007 Mar; 44(6):e67-8. PubMed ID: 17304444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Torsade-de-pointes in a patient under flecainide treatment, an unusual case of proarrhythmicity.
    Nogales Asensio JM; Moreno Sánchez N; Doncel Vecino LJ; Villar Mariscal C; López-Mínguez JR; Merchán Herrera A
    Int J Cardiol; 2007 Jan; 114(2):E65-7. PubMed ID: 17056139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Torsades de pointes ventricular tachycardia induced by intravenous amiodarone].
    Makai A; Rudas L; Liszkai G; Fazekas T
    Orv Hetil; 2003 Feb; 144(5):241-7. PubMed ID: 12647553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sotalol-induced torsades de pointes in patients with renal failure.
    Dancey D; Wulffhart Z; McEwan P
    Can J Cardiol; 1997 Jan; 13(1):55-8. PubMed ID: 9039065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Torsades de pointes associated with fluoroquinolones: importance of concomitant risk factors.
    Amankwa K; Krishnan SC; Tisdale JE
    Clin Pharmacol Ther; 2004 Mar; 75(3):242-7. PubMed ID: 15001976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ciprofloxacin induced acquired long QT syndrome in a patient under class III antiarrhythmic therapy.
    Keivanidou A; Arnaoutoglou C; Krommydas A; Papanikolaou G; Tsiptses K; Chrisopoulos C; Kirpizidis C
    Cardiol J; 2009; 16(2):172-4. PubMed ID: 19387967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Amiodarone-induced torsade de pointes--five case reports].
    Kukla P; Słowiak-Lewińska T
    Kardiol Pol; 2004 Apr; 60(4):365-70; discussion 371. PubMed ID: 15226788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Q-T prolongation and torsades de pointes ventricular tachycardia produced by the tetracyclic antidepressant agent maprotiline.
    Herrmann HC; Kaplan LM; Bierer BE
    Am J Cardiol; 1983 Mar; 51(5):904-6. PubMed ID: 6829452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Apropos of a rare cause of torsades de pointe: hypokalemia caused by dietary deficiency].
    Chavernac P; Navarrot P; Ravoteur B; Maurette M; Heraudeau A
    Ann Cardiol Angeiol (Paris); 1992 Jun; 41(6):339-42. PubMed ID: 1444160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of allergic cross reaction between tricyclic antidepressants and maprotiline].
    Shimizu K; Watanabe M; Kodama Y; Nomura S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1998 Aug; 18(4):129-32. PubMed ID: 9866828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Citalopram and Torsades de Pointes. A case report].
    Meuleman C; Jourdain P; Bellorini M; Sadeg N; Loiret J; Guillard N; Thebault B; Funck F
    Arch Mal Coeur Vaiss; 2001 Sep; 94(9):1021-4. PubMed ID: 11603066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moxifloxacin and torsade de pointes.
    Dale KM; Lertsburapa K; Kluger J; White CM
    Ann Pharmacother; 2007 Feb; 41(2):336-40. PubMed ID: 17284508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.